Literature DB >> 24962703

ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas.

M Wilhelm1, U Dirksen2, S S Bielack3, J S Whelan4, I J Lewis5, H Jürgens2, S Ferrari6, K Sundby Hall7, A M Cleton-Jansen8, D Stark9.   

Abstract

Teenagers and young adults (TYA) cancer contributes substantially to morbidity and mortality in a population with much to offer society. TYA place distinct challenges upon cancer care services, many reporting feeling marginalized and their needs not being met in adult or paediatric cancer services. Bone tumours such as osteosarcoma and Ewing sarcoma, because of their age at presentation and the complexity of their care, are where challenges in managing (TYA) with cancer have often been most readily apparent. Bone sarcomas may be managed by paediatric or medical oncologists, and require fastidious attention to protocol. A lack of recent improvement in survival in TYA with bone tumours may be linked to a lack of specialist care, poor concordance with therapy in some situations and TYA-specific pharmacology. Participation in clinical trials, particularly of young adults, is low, hindering progress. All these requirements may be best met by a concerted effort to create collaborative care between adult and paediatric experts in bone sarcoma, working together to meet TYA patients' needs.
© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ewing sarcoma; adolescents and young adults (AYA); bone tumours; osteosarcoma; teenage and young adults (TYA)

Mesh:

Year:  2014        PMID: 24962703     DOI: 10.1093/annonc/mdu153

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  3 in total

Review 1.  Adolescent and young adult patients with cancer: a milieu of unique features.

Authors:  Leonard Sender; Keri B Zabokrtsky
Journal:  Nat Rev Clin Oncol       Date:  2015-05-26       Impact factor: 66.675

2.  Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research.

Authors:  Arthur Felix; Pablo Berlanga; Maud Toulmonde; Judith Landman-Parker; Sarah Dumont; Gilles Vassal; Marie-Cécile Le Deley; Nathalie Gaspar
Journal:  Cancer Med       Date:  2021-01-15       Impact factor: 4.452

3.  Survival after cancer in children, adolescents and young adults in the Nordic countries from 1980 to 2013.

Authors:  Klaus Rostgaard; Henrik Hjalgrim; Laura Madanat-Harjuoja; Tom B Johannesen; Sofia Collin; Lisa L Hjalgrim
Journal:  Br J Cancer       Date:  2019-11-13       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.